Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vega

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Anales De Pediatria (Barcelona, Spain : 2003)|June 8, 2006
[Submandibular tumor]J M García Puga, Maria V Ramos Ramos, F Muwaqued Rodríguez, et al.
Plos One|May 4, 2019
Application of CNTF or FGF-2 increases the number of M2-like macrophages after optic nerve injury in adult Rana pipiensRosa E Blanco, Giam S Vega-Meléndez, Valeria De La Rosa-Reyes, et al.
Journal of Medicinal Chemistry|October 10, 1998
Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replicationE Arranz, J A Díaz, S T Ingate, et al.
Medicina Clinica|June 10, 2000
[Orthostatic hypotension in the aged and its association with antihypertensive treatment]T Sáez, C Suárez, M J Sierra, et al.
Public Health|August 18, 2004
Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central SpainJ M Morales, F P Bermejo, J Benito-León, et al.
European Journal of Medicinal Chemistry|August 26, 2000
Synthesis and pharmacological evaluation of 2, 3-dihydro-3-oxo-4H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockersE Arranz, J A Díaz, S Vega, et al.
Revista De Neurologia|January 11, 2002
[Hyperdense cerebral abscess. A case report]V R Cerrón Rojas, S Silva Adán, S Vega-Basulto, et al.
The Pharmacogenomics Journal|August 3, 2010
Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K arrayK Miclaus, R Wolfinger, S Vega, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitorsM E Arranz, J A Díaz, S T Ingate, et al.
Archiv Der Pharmazie|November 1, 1994
4H-pyrrolo[1,2-a]thieno[3,2-f] and 4H-pyrrolo[1,2-a]thieno-[2,3-f][1,4]diazepines: synthesis and pharmacological evaluationS Vega, M S Gil, V Darias, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Anales De Pediatria (Barcelona, Spain : 2003)|June 8, 2006
[Submandibular tumor]J M García Puga, Maria V Ramos Ramos, F Muwaqued Rodríguez, et al.
Plos One|May 4, 2019
Application of CNTF or FGF-2 increases the number of M2-like macrophages after optic nerve injury in adult Rana pipiensRosa E Blanco, Giam S Vega-Meléndez, Valeria De La Rosa-Reyes, et al.
Journal of Medicinal Chemistry|October 10, 1998
Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replicationE Arranz, J A Díaz, S T Ingate, et al.
Medicina Clinica|June 10, 2000
[Orthostatic hypotension in the aged and its association with antihypertensive treatment]T Sáez, C Suárez, M J Sierra, et al.
Public Health|August 18, 2004
Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central SpainJ M Morales, F P Bermejo, J Benito-León, et al.
European Journal of Medicinal Chemistry|August 26, 2000
Synthesis and pharmacological evaluation of 2, 3-dihydro-3-oxo-4H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockersE Arranz, J A Díaz, S Vega, et al.
Revista De Neurologia|January 11, 2002
[Hyperdense cerebral abscess. A case report]V R Cerrón Rojas, S Silva Adán, S Vega-Basulto, et al.
The Pharmacogenomics Journal|August 3, 2010
Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K arrayK Miclaus, R Wolfinger, S Vega, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitorsM E Arranz, J A Díaz, S T Ingate, et al.
Archiv Der Pharmazie|November 1, 1994
4H-pyrrolo[1,2-a]thieno[3,2-f] and 4H-pyrrolo[1,2-a]thieno-[2,3-f][1,4]diazepines: synthesis and pharmacological evaluationS Vega, M S Gil, V Darias, et al.
Pageof 19